Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure

被引:328
作者
Ernst, ME
Carter, BL
Goerdt, CJ
Steffensmeier, JJG
Phillips, BB
Zimmerman, MB
Bergus, GR
机构
[1] Univ Iowa, Coll Pharm, Div Clin & Adm Pharm, Iowa City, IA 52242 USA
[2] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Family Med, Iowa City, IA USA
[3] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA USA
[4] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA USA
[5] Vet Affairs Med Ctr, Dept Pharm, Iowa City, IA 52242 USA
[6] Univ Iowa Hosp & Clin, Dept Pharmaceut Care, Iowa City, IA 52242 USA
关键词
diuretics; blood pressure monitoring; ambulatory; antihypertensive agents; hypertension; essential; antihypertensive therapy;
D O I
10.1161/01.HYP.0000203309.07140.d3
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Low-dose thiazide-type diuretics are recommended as initial therapy for most hypertensive patients. Chlorthalidone has significantly reduced stroke and cardiovascular end points in several landmark trials; however, hydrochlorothiazide remains favored in practice. Most clinicians assume that the drugs are interchangeable, but their antihypertensive effects at lower doses have not been directly compared. We conducted a randomized, single-blinded, 8-week active treatment, crossover study comparing chlorthalidone 12.5 mg/day (force-titrated to 25 mg/day) and hydrochlorothiazide 25 mg/day (force-titrated to 50 mg/day) in untreated hypertensive patients. The main outcome, 24-hour ambulatory blood pressure ( BP) monitoring, was assessed at baseline and week 8, along with standard office BP readings every 2 weeks. Thirty patients completed the first active treatment period, whereas 24 patients completed both. An order - drug - time interaction was observed with chlorthalidone; therefore, data from only the first active treatment period was considered. Week 8 ambulatory BPs indicated a greater reduction from baseline in systolic BP with chlorthalidone 25 mg/day compared with hydrochlorothiazide 50 mg/day (24-hour mean = - 12.4 +/- 1.8 mm Hg versus - 7.4 +/- 1.7 mm Hg; P = 0.054; nighttime mean = - 13.5 +/- 1.9 mm Hg versus - 6.4 +/- 1.8 mm Hg; P = 0.009). Office systolic BP reduction was lower at week 2 for chlorthalidone 12.5 mg/day versus hydrochlorothiazide 25 mg/day ( - 15.7 +/- 2.2 mm Hg versus - 4.5 +/- 2.1 mm Hg; P = 0.001); however, by week 8, reductions were statistically similar ( - 17.1 +/- 3.7 versus - 10.8 +/- 3.5; P = 0.84). Within recommended doses, chlorthalidone is more effective in lowering systolic BPs than hydrochlorothiazide, as evidenced by 24-hour ambulatory BPs. These differences were not apparent with office BP measurements.
引用
收藏
页码:352 / 358
页数:7
相关论文
共 42 条
  • [21] DOUBLE-BLIND-STUDY OF CHLORTHALIDONE AND HYDROCHLOROTHIAZIDE IN AN OUTPATIENT POPULATION OF MODERATE HYPERTENSIVES
    FINNERTY, FA
    [J]. ANGIOLOGY, 1976, 27 (12) : 738 - 744
  • [22] Ambulatory blood pressure and mortality - A population-based study
    Hansen, TW
    Jeppesen, J
    Rasmussen, S
    Ibsen, H
    Torp-Pedersen, C
    [J]. HYPERTENSION, 2005, 45 (04) : 499 - 504
  • [23] Randomised trial of old and new antihypertensive drugs in elderly patients:: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
    Hansson, L
    Lindholm, LH
    Ekbom, T
    Dahlöf, B
    Lanke, J
    Scherstén, B
    Wester, PO
    Hedner, T
    de Faire, U
    [J]. LANCET, 1999, 354 (9192) : 1751 - 1756
  • [24] Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives
    Kario, K
    Pickering, TG
    Matsuo, T
    Hoshide, S
    Schwartz, JE
    Shimada, K
    [J]. HYPERTENSION, 2001, 38 (04) : 852 - 857
  • [25] Khosla Nitin, 2005, J Clin Hypertens (Greenwich), V7, P354, DOI 10.1111/j.1524-6175.2005.04451.x
  • [26] Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality - The Ohasama Study
    Kikuya, M
    Ohkubo, T
    Asayama, K
    Metoki, H
    Obara, T
    Saito, S
    Hashimoto, J
    Totsune, K
    Hoshi, H
    Satoh, H
    Imai, Y
    [J]. HYPERTENSION, 2005, 45 (02) : 240 - 245
  • [27] TREATMENT OF MILD HYPERTENSION STUDY - FINAL RESULTS
    NEATON, JD
    GRIMM, RH
    PRINEAS, RJ
    STAMLER, J
    GRANDITS, GA
    ELMER, PJ
    CUTLER, JA
    FLACK, JM
    SCHOENBERGER, JA
    MCDONALD, R
    LEWIS, CE
    LIEBSON, PR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (06): : 713 - 724
  • [28] Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study
    Ohkubo, T
    Hozawa, A
    Yamaguchi, J
    Kikuya, M
    Ohmori, K
    Michimata, M
    Matsubara, M
    Hashimoto, J
    Hoshi, H
    Araki, T
    Tsuji, I
    Satoh, H
    Hisamichi, S
    Imai, Y
    [J]. JOURNAL OF HYPERTENSION, 2002, 20 (11) : 2183 - 2189
  • [29] Recommendations for blood pressure measurement in humans and experimental animals - Part 1: Blood pressure measurement in humans - A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research
    Pickering, TG
    Hall, JE
    Appel, LJ
    Falkner, BE
    Graves, J
    Hill, MN
    Jones, DW
    Kurtz, T
    Sheps, SG
    Roccella, EJ
    [J]. CIRCULATION, 2005, 111 (05) : 697 - 716
  • [30] Meta-analysis of health outcomes of chlorthaliclone-based vs nonchlorthaliclone-based low-dose diuretic therapies
    Psaty, BM
    Lumley, T
    Furberg, CD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (01): : 43 - 44